Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07834268
NA

Feasibility of Multi-cancer Early Detection Test in Screening Population (NQMD-CS)

Sponsor: Fifth Affiliated Hospital of Guangzhou Medical University

View on ClinicalTrials.gov

Summary

This is a prospective, multicenter screening cohort study designed to evaluate the feasibility of a blood-based multi-cancer early detection (MCED) test in an asymptomatic screening population. Eligible participants will undergo blood-based MCED testing, standard cancer screening as appropriate, and 1-year active follow-up. Participants with positive MCED results or highly suspicious findings from standard screening will undergo diagnostic evaluation to determine cancer status, enabling a more accurate assessment of the test's clinical performance.

Official title: NQMD-CS: A Prospective Interventional Study to Evaluate the Feasibility of a Blood-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population

Key Details

Gender

All

Age Range

40 Years - 74 Years

Study Type

INTERVENTIONAL

Enrollment

1250

Start Date

2025-07-02

Completion Date

2026-10

Last Updated

2026-09-22

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

MCED

A cfDNA methylation-based early cancer detection model that provides a binary positive/negative result and predicts the tissue of origin when a cancer-associated signal is detected.

Locations (2)

The Fifth Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Huidong People's Hospital

Huizhou, Guangdong, China